Shares of OptiNose OPTN soared 52.5% on Thursday after the company announced that it is set to be acquired by Paratek Pharmaceuticals, a private biotech. This deal will add OPTN’s approved ...

Supinoxin blocks SCLC progression through the DDX5 protein. Researchers in Tran's lab published results in 2020 showing that DDX5 helps support the cancer's malignant growth. DDX5 belongs to a ...